Becton Dickinson and Co
NYSE:BDX
Becton Dickinson and Co
NYSE:BDX
Price:
231.97 USD
2.29%
Market Closed
Updated:
Jun 1, 2024
Becton Dickinson and Co
Stock-Based Compensation
|
Becton Dickinson and Co
Stock-Based Compensation Peer Comparison
Comparables:
BSX
EW
SYK
ABT
ISRG
Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Stock-Based Compensation
$257m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Stock-Based Compensation
$241m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Stock-Based Compensation
$139.4m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Stock-Based Compensation
$218m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Stock-Based Compensation
$606.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
See Also
What is Becton Dickinson and Co's Stock-Based Compensation?
Stock-Based Compensation
257m
USD
257m
USD
Based on the financial report for Mar 31, 2024, Becton Dickinson and Co's Stock-Based Compensation amounts to 257m USD.
What is Becton Dickinson and Co's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
9%
9%
Over the last year, the Stock-Based Compensation growth was 5%. The average annual Stock-Based Compensation growth rates for Becton Dickinson and Co have been 3% over the past three years , -1% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
